DNA damage responses after exposure to DNA-based products

Journal of Gene Medicine

Volumn 8, Issue 2, 2006, Pages 175-185

  Smith, Catherine C ^a   Aylott, Michael C ^b   Fisher, Krishna J ^c   Lynch, Anthony M ^b   Gooderham, Nigel J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

Author keywords

DNA damage; Insertional mutagenesis; Plasmid vectors; Repair gene therapy; Viral vectors

Indexed keywords

ATM PROTEIN; ATR PROTEIN; BIOLOGICAL MARKER; CHECKPOINT KINASE 2; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA BINDING PROTEIN; DOUBLE STRANDED DNA; ETOPOSIDE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; MESYLIC ACID METHYL ESTER; PROTEIN C FOS; RAD51 PROTEIN; RAD52 PROTEIN; RAD54 PROTEIN; REPLICATION PROTEIN A; RETROVIRUS VECTOR; VIRUS VECTOR;

ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; EXPOSURE; GENE EXPRESSION; GENE IDENTIFICATION; GENE INSERTION; GENETIC ANALYSIS; GENETIC TRANSFECTION; GENOTOXICITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; RNA ANALYSIS; STRESS;

CELL LINE; DEPENDOVIRUS; DNA; DNA DAMAGE; DNA REPAIR ENZYMES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MUTAGENICITY TESTS; PLASMIDS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 32844466386     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jgm.827     Document Type: Article

References (41)

1. Hacein-Bey-Abina S, le Demist F, Carlier F, et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002; 346: 1185-1193.
2. Check E. Regulators split on gene therapy as patient shows signs of cancer. Nature 2002; 419: 545-546.
3. Check E. Second cancer case halts gene-therapy trials. Nature 2003; 421: 305.
4. Kaiser J. RAC hears a plea for resuming trials, despite cancer risk. Science 2003; 299: 991.
5. NIH Guidelines for Research involving Recombinant DNA Molecules. Available: http://www4.od.nih.gov/oba/Rdna.htm.
6. Smith CC, Lynch AM, Gooderham NJ. Evaluating the Genetic toxicology of DNA-based products using existing genetic toxicology assays. Mutagenesis 2003; 18: 259-264.
7. Shen Z, Peterson SR, Comeaux JC, et al. Self-association of human RAD52 protein. Mut Res 1996; 364: 81-89.
8. Takata M, Sasaki MS, Sonoda E, et al. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J 1998; 17: 5497-5508.
9. Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. Curr Opin Genet Develop 200; 11: 71-77.
10. Lai CM, Lai YK, Rakoczy PE. Adenovirus and adeno-associated virus vectors. DNA Cell Biol 2002; 21: 895-913.
11. Holmes-Son ML, Appa RS, Chow SA. Molecular genetics and target site specificity of retroviral integration. Adv Gen 2001; 43: 33-69.
12. Dogliotti E, Fortini P, Pascucci B, Parlanti E. The mechanism of switching among multiple BER pathways. Prog Nucleic Acid Res Mol Biol 2001; 68: 3-27.
13. Ono Y, Matsumoto K, Furuta T, et al. Relationship between expression of a major apurinic/apyrimidinic endonuclease (APEX nuclease) and susceptibility to genotoxic agents in human glioma cell lines. J Neuro-Oncol 1995; 25: 183-195.
14. Zonneveld A, Veerman H, MacDonald ME, et al. Structure and function of the human tissue-type plasminogen activator. J Cell Biochem 1986; 32: 169-177.
15. Gibbs PE, McGregor WG, Maher VM, et al. A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of polymerase zeta. Proc Natl Acad Sci 1998; 97: 6876-6880.
16. Golub EI, Gupta RC, Haaf T, et al. Interaction of human rad51 recombination protein with single-stranded DNA binding protein, RPA. Nucleic Acids Res 1998; 26: 5388-5393.
17. Dualan R, Brody T, Keeney S, et al. Chromosomal localisation and cDNA cloning of the genes (DDB1 and DDB2) for the p127 and p48 subunits of a human damage-specific DNA binding protein. Genomics 1995; 29: 62-69.
18. Fornace AJ, Jackman J, Hollander MC, et al. Genotoxic-stress-response genes and growth-arrest genes. Annal NY Acad Sci 1992; 663: 139-153.
19. Richards CA, Brown CE, Cogswell JP, et al. The Admid system: generation of recombinant adenoviruses by Tn7-mediated transposition in E. coil. Biotechniques 2000; 29: 596-601.
20. Fisher KJ, Gao GP, Weitzman MD, et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J Virol 1996; 70: 520-532.
21. Sobol RW, Wilson SH. Mammalian DNA beta-polymerase in base excision repair of alkylation damage. Prog Nucleic Acid Res Mol Biol 2001; 68: 57-74.
22. Grzesiuk E. Role of mutation frequency decline and SOS repair systems in methyl methanesulfonate mutagenesis. Acta Biochim Pol 1998; 45: 523-533.
23. Willmore E, Frank AJ, Padget K, et al. Etoposide targets topoisomerase IIalpha and IIbeta in leukemic cells: isoform-specific cleavable complexes visualized and quantified in situ by a novel immunofluorescence technique. Mol Pharm 1998; 54: 78-85.
24. Ashby J, Tinwell H, Glover P, et al. Potent clastogenicity of the human carcinogen etoposide to the mouse bone marrow and mouse lymphoma L5178Y cells: comparison to Salmonella responses. Environ Mol Mut 1994; 24: 51-60.
25. Clive D, Glover P, Applegate M, Hozier J. Molecular aspects of chemical mutagenesis in L5178Y/tk +/- mouse lymphoma cells. Mutagenesis 1990; 2: 191-197.
26. Hande KR. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur J Cancer 1998; 34: 1514-1521.
27. Jensen LH, Nitiss KC, Rose A, et al. A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines. J Bioi Chem 2000; 275: 2137-2146.
28. Sugiyama T, New JH, Kowalczykowski SC. DNA annealing by RAD52 protein is stimulated by specific interaction with the complex of replication protein A and single-stranded DNA. Proc Natl Acad Sci 1998; 95: 6049-6054.
29. Shao RG, Cao CX, Zhang H, et al. Replication-mediated DNA damage by camptothecin induces phosphorylation of RPA by DNA-dependent protein kinase and dissociates RPA:DNA-PK complexes. EMBO J 1999; 18: 1397-1406.
30. Daniel R, Katz RA, Skalka AM. A role for DNA-PK in retroviral DNA integration. Science 1999; 284: 644-647.
31. Daniel R, Kao G, Taganov K, et al. Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage response. Proc Natl Acad Sci 2003; 100: 4778-4783.
32. Bartlett JS, Wilcher R, Samulski J. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol 2000; 74: 2777-2785.
33. Ni T-H, MacDonald WF, Zolotukhin I, et al. Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection. J Virol 1998; 72: 2777-2787.
34. Zentilin L, Marcello A, Giacca M. Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome. J Virol 2001; 75: 12 279-12 287.
35. Miller DG, Petek LM, Russell DW. Human gene targeting by adeno-associated vectors is enhanced by DNA double-strand breaks. Mol Cell Biol 2003; 23: 3550-3557.
36. Green NK, Seymour LW. Adenovirul vectors: systemic delivery and tumor targeting, cancer. Gene Ther 2002; 9: 1036-1042.
37. Nadeau I, Kamen A. Production of adenovirus vector for gene therapy. Biotechnol Adv 2003; 20: 475-489.
38. Bergelson JM, Krithivas A, Celi L, et al. The murine CAR homolog is a receptor for cocksackie B viruses and adenoviruses. J Virol 1998; 72: 415-419.
39. Raptis L, de Souza AC, M'Bikay M, et al. Stable integration of adenovirus DNA is not required for the induction of mutations in the hypoxanthine phosphoribosyltransferase gene in Chinese hamster cells. Mut Res 1982; 105: 371-375.
40. Nevin NC. The UK Gene Therapy Advisory Committee has concerns regarding the safety of some lentiviral gene therapy vectors. Available: http://www.advisorybodies.doh.gov.uk/genetics/gtac/. Accessed 5 November, 2004.
41. Roberts JP. Insertional mutagenesis from a viral vector. The Scientist 2005; 19: 20-25.